Listed

Eledon Pharmaceuticals, Inc.

ELDNNasdaqCIK 1404281HealthcareFiscal year ends Dec 31

Reports and events: 214 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Eledon Pharmaceuticals, Inc., Reports and events
FiledFormWhat it isAccession number
2018-04-3013:03 ETDEF 14AProxy statementPeriod 2018-06-130001564590-18-009747
2018-04-1716:21 ETSC 13D/AOwnership report, active investor, amended0001193125-18-119824
2018-04-0221:54 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-18-007316
2018-04-0221:46 ET10-KAnnual reportPeriod 2017-12-310001564590-18-007314
2018-03-1915:16 ETSC 13D/AOwnership report, active investor, amended0000947871-18-000249
2018-03-1217:38 ET8-K8.01 Other events0001564590-18-005165
2018-01-0817:11 ETSC 13D/AOwnership report, active investor, amended0001072613-18-000016
2017-11-2917:00 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-17-024356
2017-11-0816:50 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001564590-17-022812
2017-11-0816:41 ET10-QQuarterly reportPeriod 2017-09-300001564590-17-022799
2017-11-0616:30 ET8-K5.02 Departure or appointment of officers or directors0001564590-17-021826
2017-09-2916:06 ET8-K5.07 Shareholder vote results0001193125-17-299533
2017-08-2217:15 ET8-K1.01 Entry into a material agreement; 9.01 Financial statements and exhibits0001193125-17-264684
2017-08-1806:07 ETDEF 14AProxy statementPeriod 2017-09-280001193125-17-261566
2017-08-1006:05 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-17-253437
2017-08-0916:30 ET10-QQuarterly reportPeriod 2017-06-300001193125-17-252847
2017-07-2514:55 ET8-K/A9.01 Financial statements and exhibits0001193125-17-234866
2017-07-1017:21 ET8-K5.02 Departure or appointment of officers or directors0001193125-17-225327
2017-05-3116:05 ET8-K5.02 Departure or appointment of officers or directors0001193125-17-189230
2017-05-1912:15 ETSC 13DOwnership report, active investor0000947871-17-000387
2017-05-1616:31 ETSC 13D/AOwnership report, active investor, amended0001193125-17-172186
2017-05-1516:23 ET8-K1.01 Entry into a material agreement; 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 4.01 Change of auditor; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits0001193125-17-170677
2017-05-0316:06 ET10-QQuarterly reportPeriod 2017-03-310001193125-17-156191
2017-04-2816:20 ET8-K8.01 Other events0001193125-17-148228
2017-04-2517:04 ET10-K/AAnnual report, amendedPeriod 2016-12-310001193125-17-136933
2017-03-0917:00 ET8-K3.01 Delisting notice0001193125-17-077021
2017-03-0316:07 ET10-KAnnual reportPeriod 2016-12-310001193125-17-069741
2017-02-0316:14 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 9.01 Financial statements and exhibits0001193125-17-030723
2017-01-0515:11 ETSC 13DOwnership report, active investor0001193125-17-002838
2016-12-2209:41 ET8-K1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-801307
2016-11-0306:21 ET10-QQuarterly reportPeriod 2016-09-300001193125-16-757930
2016-10-1216:07 ET8-K5.02 Departure or appointment of officers or directors0001193125-16-736743
2016-08-2216:00 ET8-K7.01 Regulation FD disclosure0001193125-16-687554
2016-08-0417:29 ET10-QQuarterly reportPeriod 2016-06-300001193125-16-672054
2016-08-0307:53 ET8-K2.05 Exit or disposal costs; 5.02 Departure or appointment of officers or directors0001193125-16-669173
2016-07-2616:00 ET8-K2.02 Results of operations; 8.01 Other events0001193125-16-658097
2016-06-1607:01 ET8-K5.07 Shareholder vote results0001193125-16-623006
2016-05-3107:12 ET8-K5.02 Departure or appointment of officers or directors0001193125-16-607178
2016-05-1007:08 ET10-QQuarterly reportPeriod 2016-03-310001193125-16-584673
2016-04-2907:31 ETDEF 14AProxy statementPeriod 2016-06-150001193125-16-566075
2016-03-1007:16 ET10-KAnnual reportPeriod 2015-12-310001193125-16-499163
2016-01-0707:30 ET8-K7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits0001193125-16-422911
2015-11-1007:44 ET10-QQuarterly reportPeriod 2015-09-300001193125-15-372762
2015-08-1216:04 ET10-QQuarterly reportPeriod 2015-06-300001193125-15-288074
2015-06-1807:01 ET8-K5.07 Shareholder vote results0001193125-15-226543
2015-06-1216:05 ET8-K1.01 Entry into a material agreement0001193125-15-221806
2015-05-1206:19 ET10-QQuarterly reportPeriod 2015-03-310001193125-15-182900
2015-04-3017:00 ETDEF 14AProxy statementPeriod 2015-06-170001193125-15-162493
2015-04-1516:30 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-15-131300
2015-03-2616:36 ET10-KAnnual reportPeriod 2014-12-310001193125-15-107051

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 13, 2026, 16:16 ET. Listed shows no prices and gives no investment advice.